Table 2.
L-Arginine transport kinetics | |||
---|---|---|---|
Vmax (pmol/ μg protein/min) | Km (μM) | Vmax/Km (pmol/ μg protein/min/(μM)) | |
Control | 1.7±0.4 | 88±23 | 0.019±0.005 |
Insulin 1 min | 2.7±0.9 | 84±18 | 0.032±0.008 |
Insulin 2 min | 2.3±0.7 | 130±22 | 0.017±0.004 |
Insulin 3 min | 3.7±1.7* | 145±28 | 0.025±0.007 |
Insulin 5 min | 3.4±1.0* | 70±12 | 0.049±0.018* |
Insulin 10 min | 1.2±0.4 | 54±16 | 0.022±0.007 |
Insulin 20 min | 1.5±0.6 | 84±12 | 0.010±0.003 |
Insulin 30 min | 9.1±1.1* | 153±18 | 0.059±0.007* |
Kinetics of saturable L-arginine transport (0–250 μM L-arginine, 2 μCi/ml L-[3H]arginine, 1 min, 37°C) was measured in HUVECs exposed (1–30 min) to Krebs solution in absence (Control), or containing 1 nM insulin (see Methods). Maximal transport capacity was determined by the Vmax/Km ratio for L-arginine transport.
P < 0.05 versus control. Values are means ± SEM (n = 10–12).